Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eiger BioPharmaceuticals
Biotech
Eiger ends hepatitis med's journey after liver damage reported
Eiger is putting a pin in efforts to advance peginterferon lambda, a drug once tried in COVID-19 that has now failed in chronic hepatitis delta.
Annalee Armstrong
Sep 13, 2023 4:30am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
Eiger descends from COVID peak after pivoting, cuts 25% of staff
Jun 29, 2023 9:52am
Veru's EUA ambitions for its COVID treatment crash
Mar 3, 2023 11:17am
FDA nixes EUA ambitions for Eiger's COVID treatment
Oct 5, 2022 10:50am
Eiger COVID therapy in limbo after murky FDA feedback
Sep 6, 2022 11:00am